Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Ivan Gergel
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:focusesOn |
peripheral nerve repair
|
| gptkbp:foundedYear |
2016
|
| gptkbp:headquartersLocation |
gptkb:Philadelphia,_Pennsylvania,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
NTX-001
|
| gptkbp:specializesIn |
regenerative medicine
|
| gptkbp:website |
https://www.neuraptive.com/
|
| gptkbp:bfsParent |
gptkb:Sol_Barer
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neuraptive Therapeutics
|